Clostridium botulinum Toxin (Daewoong Pharmaceutical)

肉毒杆菌毒素 (大熊制药)

Report date: 2025/06/11 20:01:15

Base Information

Drug NameClostridium botulinum Toxin (Daewoong Pharmaceutical)
Drug Alias NameDWP712DWP-712
ClassificationBiologics > Protein drugs > Toxin
Mechanisms of ActionSynaptosomal-associated protein 25 inhibitors
TargetsSynaptosomal-associated protein 25
Therapy Area/IndicationsGlabellar lines
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaewoong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsGlabellar lines
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A